Director of Clinical Research and Diabetes Technology, Sansum Diabetes Research Institute, Santa Barbara, CA, USA,
Diabetes Ther. 2010 Aug;1(1):10-24. doi: 10.1007/s13300-010-0004-6. Epub 2010 Sep 13.
This review of insulin pump therapy focuses on the OmniPod® Insulin Management System (Insulet Corp., Bedford, MA, USA). The OmniPod System is the first commercially available "patch pump." It is a fully integrated wearable pump, controlled wirelessly through a handheld device containing a built-in blood glucose meter. This is an evaluation of the OmniPod System, with the aim of providing an educational tool for physicians who are considering recommending this product to their patients. The review includes a discussion of the traditional insulin pump configuration and its limitations, a detailed overview of the OmniPod System, references to clinical study data, planned product enhancements, its use as an insulin delivery system in the Juvenile Diabetes Research Foundation's Artificial Pancreas Project, and its use to deliver additional compounds.
这篇胰岛素泵治疗综述的重点是 OmniPod®胰岛素管理系统(Insulet 公司,美国马萨诸塞州贝德福德)。OmniPod 系统是首个商业化的“贴片泵”。它是一种完全集成的可穿戴式胰岛素泵,通过包含内置血糖仪的手持设备进行无线控制。这是对 OmniPod 系统的评估,旨在为考虑向患者推荐该产品的医生提供教育工具。该综述包括对传统胰岛素泵配置及其局限性的讨论、对 OmniPod 系统的详细概述、临床研究数据的参考、计划中的产品增强功能、它在青少年糖尿病研究基金会人工胰腺项目中作为胰岛素输送系统的应用,以及它在输送其他化合物方面的应用。